Semaglutide vs P21

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Semaglutide

Semaglutide is a GLP-1 receptor agonist that has revolutionized weight management and diabetes treatment. FDA-approved as Ozempic (diabetes), Wegovy (weight loss), and Rybelsus (oral form), it has become one of the most prescribed peptides worldwide.

Full details →

P21

P21 is a synthetic peptide derived from Cerebrolysin, specifically designed to mimic the neurotrophic effects of the parent compound. It promotes neurogenesis and has shown cognitive-enhancing properties in research.

Full details →

Side-by-Side Comparison

AspectSemaglutideP21
MechanismMimics glucagon-like peptide-1 (GLP-1) to stimulate insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite through hypothalamic signaling. The result is significant reduction in food intake and improved glycemic control.Inhibits glycogen synthase kinase-3β (GSK-3β) and activates CREB signaling pathway. This promotes BDNF expression, neurogenesis in the hippocampus, and synaptic plasticity.
Typical DosageWegovy (weight loss): Start at 0.25mg weekly, titrate up to 2.4mg weekly over 16-20 weeks. Ozempic (diabetes): 0.25mg to 1mg weekly. Research protocols vary.Research protocols typically use 1-5mg administered intranasally or subcutaneously. Often used in cycles of 2-4 weeks.
AdministrationSubcutaneous injection once weekly, typically in abdomen, thigh, or upper arm. Rybelsus is taken orally on empty stomach. Dose titration is essential to minimize GI side effects.Can be administered intranasally for direct CNS access or subcutaneously. Best used cyclically rather than continuously.
Side EffectsCommon: nausea, vomiting, diarrhea, constipation, abdominal pain. These typically decrease over time. May cause injection site reactions.Limited data. Reported effects include mild headache, temporary brain fog during initial use, and fatigue.
Best For

Key Differences

Unique to Semaglutide:

Unique to P21:

Ready to Learn More?